Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stantec (STN) Asset Writedowns and Impairment: 2009-2025

Historic Asset Writedowns and Impairment for Stantec (STN) over the last 6 years, with Sep 2025 value amounting to -$1.2 million.

  • Stantec's Asset Writedowns and Impairment fell 105.51% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.6 million, marking a year-over-year decrease of 32.45%. This contributed to the annual value of $25.0 million for FY2024, which is 11135.96% up from last year.
  • Per Stantec's latest filing, its Asset Writedowns and Impairment stood at -$1.2 million for Q3 2025, which was down 90.13% from -$649,541 recorded in Q2 2025.
  • In the past 5 years, Stantec's Asset Writedowns and Impairment ranged from a high of $33.0 million in Q4 2021 and a low of -$3.4 million during Q3 2021.
  • For the 3-year period, Stantec's Asset Writedowns and Impairment averaged around $3.6 million, with its median value being -$649,541 (2025).
  • As far as peak fluctuations go, Stantec's Asset Writedowns and Impairment tumbled by 138.25% in 2021, and later soared by 1,136.96% in 2024.
  • Over the past 5 years, Stantec's Asset Writedowns and Impairment (Quarterly) stood at $33.0 million in 2021, then slumped by 104.02% to -$1.3 million in 2022, then skyrocketed by 277.25% to $2.4 million in 2023, then surged by 30.96% to $3.1 million in 2024, then tumbled by 105.51% to -$1.2 million in 2025.
  • Its Asset Writedowns and Impairment stands at -$1.2 million for Q3 2025, versus -$649,541 for Q2 2025 and $3.1 million for Q4 2024.